Board of Directors

Board of Directors

Ted Moroz

Ted Moroz

Chair of the Board

Ted Moroz has been President of The Beer Store and Brewers' Distributor Limited since September, 2009. In this role he oversees 450 Retail Stores in Ontario, 16 Distribution Centres from British Columbia to Ottawa, and multiple cross-dock facilities throughout Canada, with a total of 7,000+ employees. Ted started his career with The Beer Store (then Brewers Retail Inc.) in 1989, holding various management positions over the years. The Beer Store has been a proud partner of United Food & Commercial Workers (UFCW) Local 12R24 in organizing an annual Returns For Leukemia Bottle Drive since 2006. Ted joined the LLSC National Board in 2010. 

Scott Carroll

Scott Carroll

Vice Chair

Scott A. Carroll is the resident manager of the Cincinnati, Ohio office of Jackson Lewis LLP.  Scott has represented clients across the spectrum of labor and employment law, including wrongful discharge litigation, collective bargaining,union avoidance, and human resources counseling.  He has expertise in drafting,counseling, prosecuting, and defending theft of trade secret cases and/or non-compete, non-solicitation cases.  Scott is a member of the U.S. Sixth Circuit Bar Association, the Federal Bar Association, the Ohio State Bar Association, and the Cincinnati Bar Association.  He received his B.S. degree from the University of Cincinnati in 1990, and he earned his J.D. from the University of Cincinnati -College of Law in 1993, where he was a member of the University of Cincinnati Law Review.   Scott became a member of the South Ohio chapter in 2002 and was chapter president in 2005.  

Eli Gembom

Eli Gembom

Treasurer

Eli obtained his CA designation at PricewaterhouseCoopers LLP in Toronto, where he worked in the business advisory and assurance practices. As Principal CA at Segal LLP, Eli's responsibilities include leading audit and advisory engagements. Eli specializes in delivering advisory services such as financial forecasts, cash-flow budgeting, profit improvement and transaction support. In addition, Eli plays a very active role in the firm's marketing and business development. He has experience with the preparation of business plans, financial packages and budgets reports to assist with client financing and restructuring.

Dr. Keith Humphries

Dr. Keith Humphries

Secretary & Chair of Medical & Scientific Committee

Dr. Keith Humphries, MD PhD, is a distinguished scientist and Director of the Terry Fox Laboratory of the BC Cancer Agency and Professor in the Division of Hematology of the Department of Medicine at the University of British Columbia. His long-standing research interests are focused on understanding the molecular mechanisms that regulate normal blood stem cell properties and how these are altered in leukemia. Studies in his lab have involved a stellar succession of trainees from Canada and around the world that have stimulated new approaches for expanding normal blood stem cells and provided new insights into the mechanisms of leukemic transformation. His laboratory has also been on the forefront of the use of retroviral and lentiviral - mediated gene transfer to human as well as mouse blood stem cells and has used this technology to develop powerful new models for studying how specific genes contribute to leukemia development. He is an active promoter of translational science and a collaborator on many team projects both nationally and internationally. He has a long track record of research accomplishments supported and contributions to scientific societies and journals. Dr. Humphries has been recognized by numerous prestigious awards including the 2013 Terry Fox Gold Medal and induction as a Fellow of the Royal Society of Canada.

He has been an active member of many international scientific societies. He has served in senior elected executive roles in the International Society of Experimental Hematology, and served as President and then as Editor in Chief of the associations journal, Experimental Hematology. He was a founding member in 1999 of the NCE-funded Stem Cell Network and remains active in the Canadian Stem Cell Network Foundation. He currently serves on the Scientific Advisory Board of the Hemato-Linne Stem Cell Program (centered in Lund, Sweden) and bluebird bio and has previously been an advisor to the hematology research program at Millenium and Systemix. He has previously served as an advisor to the Terry Fox Foundation and currently sits on the Medical-Scientific committee of the Leukemia Lymphoma Society of Canada.  Dr. Humphries has served on numerous review panels both nationally and internationally including serving as member of the Score Committee of the Leukemia and Lymphoma Society (USA), member and chair of the scientific panel for the Leukemia Lymphoma Society of Canada, the hematopoiesis panel of the National Cancer Institute and site visit panels for the Terry Fox Program.

Louis J. DeGennaro

Louis J. DeGennaro

Director


Louis J. DeGennaro, Ph.D., was named president and chief executive officer of The Leukemia & Lymphoma Society (LLS) in September 2014 and now leads the operations of this $300 million cancer patient advocacy agency with headquarters in White Plains, New York.

A critical member of the LLS executive leadership team, he joined LLS in 2005 and was named chief mission officer in 2009, with responsibility for leadership of LLS’s mission functions of research, patient access, education, public policy and advocacy. Dr. DeGennaro is recognized as the key architect of LLS’s cures and access agenda to help save lives of blood cancer patients as well as the LLS Therapy Acceleration Program® - a venture philanthropy endeavor that defined the role of nonprofit organizations in supporting drug discovery and development with the biotechnology industry.

Dr. DeGennaro has more than 25 years of research, drug development and executive management experience in academic and private sector settings. He received his Ph.D. in biochemistry from the University of California at San Francisco and did his post-doctoral research at the Yale University School of Medicine. His previous academic appointments include research group leader, Max Planck Institute in Munich, Germany and associate professor of neurology and cell biology, University of Massachusetts Medical School. Dr. DeGennaro's private-sector positions include senior director of molecular genetics at Wyeth Pharmaceuticals, Princeton, NJ, and executive vice president for research and development, SynX Pharma, Inc. in Toronto, Canada.

Alex Beraskow

Alex Beraskow

Director

Alex Beraskow is a retired management consultant with strong expertise in finance and information technology.  He started his career with IBM in 1969 and has worked within the IT domain since. He has had executive responsibility for 5 consulting firms since 1980 and also founded three consulting companies and sold each of them to international firms.

Currently, he is working as a corporate director for both Not-For-Profit (NFP), as well as corporate boards.  He is a former board member of Lymphoma Canada, Ottawa Singers, Opera Lyra, Rideau Club and the Rideau Tennis and Squash Club. 

Alex has an engineering degree from McGill University and MBA Degrees from McGill University and Ottawa University. He has also completed the ICD (Institute of Corporate Directors) program,

In 2013, he completed the Tour D’Afrique (a 12,000 km cycling trip from Cairo to Cape Town over a 4 month period), the Lands’ End to John O’Groats in 2014 (a 1,500 km trip across the UK), and a 3,000 km trip across New Zealand in 2016. 

Anouk Collet

Anouk Collet

Director

Anouk Collet is a UFCW Canada regional director, with responsibilities including education and training, and collective bargaining. Prior to joining the UFCW Canada National Office in 2008, Anouk Collet was the legal department coordinator for UFCW Canada Local 500, handling contract negotiations and arbitration cases from 2001 to 2008. From 1998 to 2001, she was executive assistant to the Canadian director of HERE.

Anouk is a graduate of the Université de Montréal where she completed both a Law Degree, and a Master's Degree in Industrial Relations. She is also one of the vice-presidents on the Quebec Federation of Labor and the Canadian Labour Congress (CLC) Canadian Council; sits on several UFCW Canada committees, as well as committees of the Quebec Federation of Labour; is the secretary-treasurer and co-president of the board of directors of Détail Québec, a non-profit organization financed by the provincial government to promote education and training in the retail sector.

Rick Lancaster

Rick Lancaster

Director

Rick Lancaster is a retired financial services industry senior executive and former President and CEO of CIBC Life Insurance. Rick served on a not-for-profit board supporting Scouts Canada for 7 years. He was also former chair and director of the Canadian Association of Financial Institutions in Insurance.  Rick has his CPA-CGA designation, an MBA from the University of Toronto and an HBA from the Ivey School of Business, Western University.  Rick is a 6 year survivor of NHL.

Marie Lapointe

Marie Lapointe

Director

Marie Lapointe is a senior executive in the aluminum industry with strategic planning and business improvement experience and a background in engineering. She retired from Rio Tinto as finished products Executive Director, and has held director roles at Steel Mill and Alcan.  She was Business Woman of Year for the Richelieu Sorel-Tracy region in 2014 and the work chair of United Way.  She has been a member of several associations including the Foundation of CEGEP College in Sorel-Tracy.  Marie has a Bachelors in Engineering from the University of Chicoutimi.  Marie’s mother has Acute Lymphocytic Leukemia (ALL).  

Gord McFarlane

Gord McFarlane

Director

Gord McFarlane is the Regional Director – Southern Alberta & Okanagan Valley for the CFO Centre, a provider of part time CFO’s globally.  He recently retired from Grant Thornton LLP after a 30 year career, where he was the Regional Managing Partner for Western Canada and a member of the firm’s National Management Committee. He was also the first National Managing Partner of the firm’s Advisory Services across Canada.  Gord is a FCA, FCPA and a Chartered Business Valuator.

Gord is the treasurer and a board member of the HomeSpace Society, a non-profit organization providing housing for Calgary’s homeless.  He is the past chair of the Calgary Philharmonic Orchestra and currently a trustee of the Calgary Philharmonic Orchestra Foundation.

Gord was diagnosed with Prolymphocytic Leukemia in 2015 and began treatment immediately, which included a successful stem cell transplant from his donor, his sister.  

Paul R. Meinema

Paul R. Meinema

Director

Paul Meinema is the National President of UFCW Canada — Paul is also Executive Vice President, UFCW International and a member of the UFCW International Executive Committee.

Paul Meinema’s dedication to UFCW spans four decades, going back to the early 1980s when he first volunteered to serve his co-workers as a shop steward while working at an Alberta meat processing plant.  In 1990, Paul was hired as a UFCW Canada local union representative, and later as a UFCW Canada International Representative. In 2002, Paul was elected as President of UFCW Canada Local 1400 — the largest private-sector union local in Saskatchewan.

In 2009, Paul Meinema moved from his Local 1400 presidency to join the UFCW Canada national leadership team as Executive Assistant to the National President. In 2013, Paul Meinema was elected UFCW Canada National President, and UFCW International Executive Vice President.

Kathleen Meriwether

Kathleen Meriwether

Director

Kathleen Meriwether is the Americas Leader of the Health Sciences team of Ernst & Young’s Fraud Investigation & Dispute Services practice.  Kathleen specializes in assisting health sciences companies with global risk and compliance assessments and regulatory compliance analyses.  Kathleen works closely with management teams, compliance officers and counsel to identify compliance and enforcement risks, determine potential vulnerabilities and recommend solutions from business and operational perspectives.  Kathleen also assists counsel, both outside and in-house, with fraud investigations (health care fraud and abuse, off label marketing, FCPA and other bribery and corruption), compliance inquiries and in strategizing responses to governmental subpoenas and other inquiries.  She has also worked on multiple projects assisting in-house counsel on management of significant litigation matters, from the cost management as well as investigative perspectives.

Prior to her tenure with EY, Kathleen was an Assistant United States Attorney in the U.S. Attorney’s Office for the Eastern District of Pennsylvania, focusing on health care fraud in the life sciences industry. 

Before becoming an AUSA, Kathleen spent over 16 years with Bristol-Myers Squibb Company in a number of legal, regulatory affairs and compliance positions, including as division counsel for the Oncology and Immunology franchise.  Kathleen’s industry experience includes such diverse areas as management of multi-district product liability and antitrust litigation, commercial litigation, labeling and promotional compliance, research and development, sales and marketing practices, including off-label marketing and fraud and abuse, government pricing and relationships with third parties, from contract research and sales organizations to licensors/ees and marketing partners.  Kathleen began her legal career as an associate with a national law firm based in Philadelphia.

Paul Petrelli

Paul Petrelli

Director

Paul Petrelli is a senior executive in the biotechnology/pharmaceutical industry with business leadership and marketing experience. He is currently the President of Biogen Canada and has held senior positions in the pharmaceutical industry. He is on the board of directors of several biotechnical organizations and is also on the volunteer board of the Oakville Hornets Hockey Association.  Paul has a B.Sc.in Genetics and Immunology from the University of Toronto.

Dr. Aaron D. Schimmer

Dr. Aaron D. Schimmer

Director

Aaron D. Schimmer, MD, PhD, FRCPC is a Staff Physician and Senior Scientist at the Princess Margaret Cancer Centre, University Health Network and Ontario Cancer Institute.  He is a member of the executive of the Ontario Cancer Institute and Dept. of Medical Oncology and Hematology at the Princess Margaret.  Dr. Schimmer holds the Baker Chair in Leukemia and Related Diseases at the University Health Network.  Dr. Schimmer is a Professor in the departments of Medicine and Medical Biophysics at the University of Toronto.  He is also the Past President and executive member of the Canadian Hematology Society. Dr. Schimmer is also a member of the LLSC Medical and Scientific Committee.

The Schimmer lab is focused in on developing new therapeutic strategies for leukemia with an interest in targeting unique mitochondrial and metabolic vulnerabilities in AML and AML stem cells.   He has advanced 3 drugs into clinical trial from his lab and has been the Principal Investigator on 9 additional clinical trials of novel agents for leukemia.  Dr. Schimmer is the author of over 200 publications and is an inventor on over 20 patent applications. He has received over 35 awards and honours for academic achievement including Member of the American Society of Clinical Investigation, Scholar in Clinical Research by the Leukemia and Lymphoma Society, and the Bernard and Francine Dorval young investigator award from the Canadian Cancer Society.